SPY330.30+3.33 1.02%
DIA272.81+1.37 0.50%
IXIC10,963.64+184.84 1.71%

Calithera Biosciences Q1 EPS $(0.380) Misses $(0.360) Estimate

Calithera Biosciences (NASDAQ:CALA) reported quarterly losses of $(0.380) per share which missed the analyst consensus estimate of $(0.360) by 5.56 percent. This is a 37.7 percent increase over losses of $(0.610) per

Benzinga · 05/07/2020 20:58

Calithera Biosciences (NASDAQ:CALA) reported quarterly losses of $(0.380) per share which missed the analyst consensus estimate of $(0.360) by 5.56 percent. This is a 37.7 percent increase over losses of $(0.610) per share from the same period last year.